Pathogenesis of psoriasis in the “omic” era. Part I. Epidemiology, clinical manifestation, immunological and neuroendocrine disturbancesDominik Samotij, Adam Reich, Leszek Kalinowski et al.|Advances in Dermatology and Allergology|2020Cited by 67
Pathogenesis of psoriasis in the “omic” era. Part II. Genetic, genomic and epigenetic changes in psoriasisBogusław Nedoszytko, Roman Nowicki, Aneta Szczerkowska‐Dobosz et al.|Advances in Dermatology and Allergology|2020Cited by 51
Pathogenesis of psoriasis in the “omic” era. Part III. Metabolic disorders, metabolomics, nutrigenomics in psoriasisin psoriasisAgnieszka Owczarczyk‐Saczonek, Roman Nowicki, Dorota Purzycka-Bohdan et al.|Advances in Dermatology and Allergology|2020Cited by 36
Chronic Plaque Psoriasis in Poland: Disease Severity, Prevalence of Comorbidities, and Quality of LifeDorota Purzycka-Bohdan, Aneta Szczerkowska‐Dobosz, Anna Kisielnicka et al.|Journal of Clinical Medicine|2022Cited by 20
The Analysis of a Genome-Wide Association Study (GWAS) of Overweight and Obesity in PsoriasisAnna Kisielnicka, Aneta Szczerkowska‐Dobosz, Marta Sobalska‐Kwapis et al.|International Journal of Molecular Sciences|2022Cited by 19